tiprankstipranks
Advertisement
Advertisement
Corcept Therapeutics upgraded to Buy from Neutral at UBS
PremiumThe FlyCorcept Therapeutics upgraded to Buy from Neutral at UBS
18d ago
Corcept Therapeutics Signals Big Growth After Key Wins
Premium
Company Announcements
Corcept Therapeutics Signals Big Growth After Key Wins
26d ago
Corcept Therapeutics price target raised to $75 from $60 at H.C. Wainwright
Premium
The Fly
Corcept Therapeutics price target raised to $75 from $60 at H.C. Wainwright
27d ago
Corcept Therapeutics raises FY26 revenue view to $950M-$1.05B, consensus $933.2M
PremiumThe FlyCorcept Therapeutics raises FY26 revenue view to $950M-$1.05B, consensus $933.2M
1M ago
Analyst Reiterates Buy on Corcept, Sees Upside with Unchanged $110 Target as Korlym Growth Set to Re-Accelerate and Lifyorli Ramps
Premium
Ratings
Analyst Reiterates Buy on Corcept, Sees Upside with Unchanged $110 Target as Korlym Growth Set to Re-Accelerate and Lifyorli Ramps
1M ago
Is CORT a Buy, Before Earnings?
Premium
Pre-Earnings
Is CORT a Buy, Before Earnings?
1M ago
Corcept Therapeutics price target raised to $110 from $100 at Canaccord
PremiumThe FlyCorcept Therapeutics price target raised to $110 from $100 at Canaccord
2M ago
Corcept Faces Investor Suit Over Relacorilant NDA Disclosure 
Premium
Class Action
Corcept Faces Investor Suit Over Relacorilant NDA Disclosure 
2M ago
Corcept Therapeutics price target raised to $110 from $100 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $110 from $100 at Canaccord
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100